A "hypersensitive" hypothalamic-pituitary-adrenal system could be indicative for a negative clinical high-frequency repetitive transcranial magnetic stimulation outcome in melancholic depressed patients

Brain Stimulation

Volumn 3, Issue 1, 2010, Pages 54-57

  Baeken, Chris ^a   De Raedt, Rudi ^b   Vanderhasselt, Marie Anne ^b   Leyman, Lemke ^b   Schiettecatte, Johan ^a   Poppe, Kris ^a   Anckaert, Ellen ^a   Bossuyt, Axel ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DISEASE SEVERITY; FEMALE; HAMILTON SCALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MELANCHOLIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SALIVA ANALYSIS; SINGLE BLIND PROCEDURE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; DEPRESSIVE DISORDER; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; TREATMENT FAILURE;

ADULT; AREA UNDER CURVE; DEPRESSIVE DISORDER; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT FAILURE;

EID: 75149128468     PISSN: 1935861X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brs.2009.03.008     Document Type: Article

References (22)

1. Gershon A.A., Dannon P.N., and Grunhaus L. Transcranial magnetic stimulation in the treatment of depression. Am J Psychiatry 160 (2003) 835-845
2. Brakemeier E.L., Luborzewski A., Danker-Hopfe H., et al. Positive predictors for antidepressive response to prefrontal repetitive transcranial magnetic stimulation (rTMS). J Psychiatr Res 41 (2007) 606-615
3. O'Reardon J.P., Solvason H.B., Janicak P.G., et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 62 (2007) 1208-1216
4. Ji R.R., Schlaepfer E., Aizenman C.D., et al. Repetitive transcranial magnetic stimulation activates specific regions in rat brain. Proc Natl Acad Sci U S A 95 (1998) 15635-15640
5. Keck M.E., Welt T., Post A., et al. Neuroendocrine and behavioral effects of repetitive transcranial magnetic stimulation in a psychopathological animal model are suggestive of antidepressant-like effects. Neuropsychopharmacology 24 (2001) 337-349
6. Hedges D.W., Massari C., Salyer D.L., et al. Duration of transcranial magnetic stimulation effects on the neuroendocrine stress response and coping behavior of adult male rats. Prog Neuropsychopharmacol Biol Psychiatry 27 (2003) 633-638
7. Evers S., Hengst K., and Pecuch P.W. The impact of repetitive transcranial magnetic stimulation on pituitary hormone levels and cortisol in healthy subjects. J Affect Disord 66 (2001) 83-88
8. Reid P.D., and Pridmore S. Dexamethasone suppression test reversal in rapid transcranial magnetic stimulation-treated depression. Aust N Z J Psychiatry 33 (1999) 274-277
9. Zwanzger P., Baghai T.C., Padberg F., et al. The combined dexamethasone-CRH test before and after repetitive transcranial magnetic stimulation (rTMS) in major depression. Psychoneuroendocrinology 28 (2003) 376-385
10. Porter R.J., and Gallagher P. Abnormalities of the HPA axis in affective disorders: clinical subtypes and potential treatments. Acta Neuropsychiatrica 18 (2006) 193-209
11. Keck M.E. rTMS as treatment strategy in psychiatric disorders-neurobiological concepts. Suppl Clin Neurophysiol 56 (2003) 100-116
12. Sheehan D.V., Lecrubier Y., Sheehan K.H., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 20 (1998) 22-57
13. Rush A.J., Thase M.E., and Dube S. Research issues in the study of difficult-to-treat depression. Biol Psychiatry 53 (2003) 743-753
14. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6 (1967) 278-296
15. Baeken C., De Raedt R., Leyman L., et al. The impact of one HF-rTMS session on mood and salivary cortisol in treatment resistant unipolar melancholic depressed patients. J Affect Disord 113 (2009) 568-575
16. Pruessner J.C., Kirschbaum C., Meinlschmid G., et al. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 28 (2003) 916-931
17. Fekedulegn D.B., Andrew M.E., Burchfiel C.M., et al. Area under the curve and other summary indicators of repeated waking cortisol measurements. Psychosom Med 69 (2007) 651-659
18. Hanson E.K., Maas C.J., Meijman T.F., et al. Cortisol secretion throughout the day, perceptions of the work environment, and negative affect. Ann Behav Med 22 (2000) 316-324
19. Sullivan R.M., and Gratton A. Prefrontal cortical regulation of hypothalamic-pituitary-adrenal function in the rat and implications for psychopathology: side matters. Psychoneuroendocrinology 27 (2002) 99-114
20. Wolkowitz O.M., and Reus V.I. Psychoneuroendocrine aspects of treatment-resistant mood disorders. In: Amsterdam J.D., Hornig M., and Nierenberg A.A. (Eds). Treatment-resistant mood disorders (2001), Cambridge University Press, Cambridge, UK 49-79
21. Loo C.K., Taylor J.L., Gandevia S.C., et al. Transcranial magnetic stimulation (TMS) in controlled treatment studies: are some "sham" forms active?. Biol Psychiatry 47 (2000) 325-331
22. Pridmore S. Rapid transcranial magnetic stimulation and normalization of the dexamethasone suppression test. Psychiatry Clin Neurosci 53 (1999) 33-37